Intravenous amiodarone or magnesium sulphate is not cost-beneficial prophylaxis for atrial fibrillation after coronary artery bypass surgery
2000 ◽
Vol 85
(5)
◽
pp. 690-695
◽
M.M. Treggiari-Venzi
◽
J.-L. Waeber
◽
T.V. Perneger
◽
P.M. Suter
◽
R. Adamec
◽
...
2001 ◽
Vol 45
(5)
◽
pp. 268
J Shepherd
◽
J Jones
◽
G Frampton
◽
Ł Tanajewski
◽
D Turner
◽
...
2009 ◽
Vol 12
(19)
◽
pp. 1325-1329
◽
F. Akbarzadeh
◽
B. Kazemi-Arb
◽
A. Golmohamma
◽
L. Pourafkari
2010 ◽
Vol 13
(5)
◽
pp. E311-E316
◽
W. Douglas Boyd
◽
William E. Johnson
◽
Parvez K. Sultan
◽
Thomas F. Deering
◽
Robert G. Matheny
1995 ◽
Vol 25
(1)
◽
pp. 198-202
◽
Lisa A Mendes
◽
Gilbert P Connelly
◽
Patrice A McKenney
◽
Philip J Podrid
◽
L.Adrienne Cupples
◽
...
2005 ◽
Vol 7
(2)
◽
pp. 170-174
◽
T HAKALA
◽
A VALTOLA
◽
A TURPEINEN
◽
A HEDMAN
◽
R VUORENNIEMI
◽
...
1998 ◽
Vol 135
(5)
◽
pp. 739-747
◽
James E. Tisdale
◽
I.Desmond Padhi
◽
A.David Goldberg
◽
Norman A. Silverman
◽
Charles R. Webb
◽
...
2001 ◽
Vol 1
(4)
◽
pp. 192-196
Paresh Shah
◽
Aleksandr Shpigel
◽
Thomas Wasser
◽
Mary Sabo
◽
Bruce Feldman